Neurology®
The most widely read and highly cited peer-reviewed Neurology journal
Quick Search
Advanced Search
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kinchington, P. R.
Right arrow Articles by Turse, S. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kinchington, P. R.
Right arrow Articles by Turse, S. E.
NEUROLOGY 1995;45:S13-S14
© 1995 American Academy of Neurology

Molecular basis for a geographic variation of varicella-zoster virus recognized by a peptide antibody

Paul R. Kinchington, PhD and Stephanie E. Turse, BS

From the Departments of Ophthalmology and Molecular Genetics and Biochemistry, University of Pittsburgh, PA.
Supported by Public Health Service grant EY 09397, a CORE Grant for Vision Research (EY 08098), and a Basil O'Connor Research Scholar Award from the March of Dimes Birth Defects Foundation.
Address correspondence and reprint requests to Dr. Paul R. Kinchington, Department of Ophthalmology, 1020 Eye and Ear Institute, University of Pittsburgh, 203 Lothrop Street, Pittsburgh, PA 15213.

A live attenuated varicella vaccine, derived from a Japanese isolate, is currently being widely used to modulate disease caused by varicella-zoster virus. Differentiation of the vaccine from wild-type isolates has been and will continue to be critical in the assessment of the vaccine in the United States. This has largely relied upon identification of characteristic DNA polymorphisms in the vaccine strain. In this report, we describe the identification of a new sequence polymorphism, located in the N-terminal coding sequence of open reading frame (ORF) 10. This variation results in the synthesis of an ORF 10 protein that is differentially recognized by antibodies to an ORF 10 synthetic peptide. The variation appears to be completely restricted to Japanese strains, including that used for the live attenuated varicella vaccine. As such, this polymorphism and the antibodies that differentially recognize it could prove highly useful in the assessment of the Japanese vaccine in the United States.

NEUROLOGY 1995;45(Suppl 8): S13-S14




This article has been cited by other articles:


Home page
J. Virol.Home page
V. N. Loparev, A. Gonzalez, M. Deleon-Carnes, G. Tipples, H. Fickenscher, E. G. Torfason, and D. S. Schmid
Global Identification of Three Major Genotypes of Varicella-Zoster Virus: Longitudinal Clustering and Strategies for Genotyping
J. Virol., August 1, 2004; 78(15): 8349 - 8358.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
R. J. Cohrs, D. H. Gilden, P. R. Kinchington, E. Grinfeld, and P. G. E. Kennedy
Varicella-Zoster Virus Gene 66 Transcription and Translation in Latently Infected Human Ganglia
J. Virol., June 15, 2003; 77(12): 6660 - 6665.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
S. K. Danoff, M. E. Grasso, P. B. Terry, and J. A. Flynn
Pleuropulmonary Disease Due to Pergolide Use for Restless Legs Syndrome
Chest, July 1, 2001; 120(1): 313 - 316.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
A Münchau and K P Bhatia
Pharmacological treatment of Parkinson's disease
Postgrad. Med. J., October 1, 2000; 76(900): 602 - 610.
[Full Text]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
D J BROOKS
Dopamine agonists: their role in the treatment of Parkinson's disease
J. Neurol. Neurosurg. Psychiatry, June 1, 2000; 68(6): 685 - 689.
[Full Text] [PDF]


Home page
PediatricsHome page
C. Grose
Varicella-Zoster Virus: Less Immutable Than Once Thought
Pediatrics, May 1, 1999; 103(5): 1027 - 1028.
[Full Text]